Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9738727 Anti-HtrA1 antibodies and methods of use

Patent 9738727 was granted and assigned to Genentech on August, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Genentech

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

97387270

Patent Inventor Names

Wei-Ching Liang0

Yan Wu0

Daniel Kirchhofer0

Kenneth J. Katschke, Jr.0

Menno van Lookeren-Campagne0

Michael Terry Lipari0

Paul M. Moran0

Scott Stawicki0

Date of Patent

August 22, 2017

Patent Application Number

136512890

Date Filed

October 12, 2012

Patent Citations Received

‌

US Patent 11866472 Peptide for treating retinitis pigmentosa

‌

US Patent 11760797 Anti-interleukin-33 antibodies and uses thereof

Patent Primary Examiner

‌

Sharon Wen

Patent abstract

The invention provides anti-HtrA1 antibodies and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9738727 Anti-HtrA1 antibodies and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API